Alex Thompson Stock Analyst Profile - Stifel Research Coverage - Stocknear

Alex Thompson

Stock Analyst at Stifel

(4.3)
# 1684
Out of 5,506 analysts
48
Total ratings
Success rate
Average return

22 Stocks

Name Action PT Current % Upside Ratings Updated
DNTH Dianthus Therapeutic...
Maintains: Strong Buy
52 65
34.94 86.03% 2 Sep 12, 2025
TVTX Travere Therapeutics
Maintains: Hold
20 25
24.64 1.46% 4 Sep 12, 2025
ASND Ascendis Pharma
Maintains: Strong Buy
212 254
204.05 24.48% 3 Aug 8, 2025
CGEM Cullinan Therapeutic...
Reinstates: Buy
22
5.9 272.88% 1 Jun 11, 2025
KYMR Kymera Therapeutics
Reinstates: Buy
55
57.9 -5.01% 1 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 5
n/a n/a 2 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
13.4 168.66% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
40.86 46.84% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
n/a n/a 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
800 -37.5% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
15.89 239.84% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
3.6 -44.44% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
8.43 718.51% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.86 -46.24% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
21.65 84.76% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
30.14 961.71% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
16.9 101.18% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.52 2071.05% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
n/a n/a 1 Sep 7, 2022